Microscopic clearance with ivermectin–permethrin combination vs. permethrin alone in noncrusted scabies: a retrospective cohort study
Clinical and Experimental Dermatology · 24.07.2026 · 51 (8) · 1442-1448
DOI: 10.1093/ced/llag113 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 13.03.2026. Verfasst von Ye Ji Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Permethrin, Scabies, Ivermectin, Insecticides. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
Scabies is a common problem in dermatology clinics, with an increasing burden in long-term care hospitals (LTCHs). Recent guidelines recognize both topical 5% permethrin and oral ivermectin as first-line treatment options for noncrusted scabies, whereas combination therapy is primarily recommended for crusted scabies. Management in routine practice remains challenging, particularly in patients with a heavier infestation, and evidence supporting combination strategies in noncrusted scabies remains limited.
Objectives
To evaluate real-world microscopic treatment outcomes of oral ivermectin plus topical permethrin compared with permethrin monotherapy, including time to microscopic cure and microscopic persistence at weeks 2 and 4.
Methods
We conducted a retrospective cohort study of 429 outpatients with microscopically confirmed noncrusted scabies at a single Korean centre (2018–25). Patients received weekly topical permethrin plus oral ivermectin (200 µg kg–1) (n = 204) or topical permethrin alone (n = 225) according to routine clinical practice.
Results
Time to microscopic cure was shorter with combination therapy than with monotherapy [mean 2.10 (SD 0.90) vs. 2.31 (SD 1.09) weeks, P = 0.03]. At week 2, microscopic persistence occurred in 30.4% (62/204) of the combination group and 35.1% (79/225) of the monotherapy group (P = 0.35). By week 4, persistent positivity occurred only in the monotherapy group [0% (0/204) vs. 3.1% (7/225), P = 0.02].
Conclusions
In a real-world outpatient setting, ivermectin–permethrin combination therapy was associated with earlier microscopic clearance than permethrin monotherapy. These findings suggest that combination therapy may be considered in selected patients with a heavier infestation or in settings where rapid parasitological clearance is a priority.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
ORCID-Profile: Ye Ji Kim
Zitieren
APA
Kim, Y. J., Kim, S. M., Jung, H. C., Kim, S. S., & Kim, C. W. (2026). Microscopic clearance with ivermectin–permethrin combination vs. permethrin alone in noncrusted scabies: a retrospective cohort study. Clinical and Experimental Dermatology, 51(8), 1442-1448. https://doi.org/10.1093/ced/llag113
Vancouver
Kim YJ, Kim SM, Jung HC, Kim SS, Kim CW. Microscopic clearance with ivermectin–permethrin combination vs. permethrin alone in noncrusted scabies: a retrospective cohort study. Clinical and Experimental Dermatology. 2026;51(8):1442-1448. doi:10.1093/ced/llag113
BibTeX
@article{Kim2026,
author = {Kim, Ye Ji and Kim, Su Min and Jung, Hyun Chul and Kim, Sang Seok and Kim, Chul Woo},
title = {Microscopic clearance with ivermectin–permethrin combination vs. permethrin alone in noncrusted scabies: a retrospective cohort study},
journal = {Clinical and Experimental Dermatology},
year = {2026},
volume = {51},
number = {8},
pages = {1442--1448},
doi = {10.1093/ced/llag113}
}
EUVIMED